Veeva Systems Inc: Form 10-Q for the period ended Oct 31, 2020
Filed with the SEC on Dec 9, 2020 and accepted by EDGAR at Dec 9, 2020, 21:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-08-01 to 2020-10-31 | $377.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-02-01 to 2020-10-31 | $1.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-08-01 to 2020-10-31 | $103.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-02-01 to 2020-10-31 | $295.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-08-01 to 2020-10-31 | $274.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-02-01 to 2020-10-31 | $773.2m | us-gaap:GrossProfit |
| Research and development | 3 months2020-08-01 to 2020-10-31 | $80.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-02-01 to 2020-10-31 | $212.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-08-01 to 2020-10-31 | $101.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-02-01 to 2020-10-31 | $279.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-08-01 to 2020-10-31 | $7.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-02-01 to 2020-10-31 | $11.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-08-01 to 2020-10-31 | $97.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-02-01 to 2020-10-31 | $277.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-08-01 to 2020-10-31 | $0.60 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-02-01 to 2020-10-31 | $1.73 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-08-01 to 2020-10-31 | $0.64 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-02-01 to 2020-10-31 | $1.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-08-01 to 2020-10-31 | 161,711,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-02-01 to 2020-10-31 | 160,517,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2020-08-01 to 2020-10-31 | $95.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2020-02-01 to 2020-10-31 | $482.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2020-10-31 | $634.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-10-31 | $1.85bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-10-31 | $2.58bn | us-gaap:Assets |
| Current liabilities | At period end2020-10-31 | $417.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-10-31 | $477.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-10-31 | $2.11bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-20-017286. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.